The pharmacy chain and the insurer have been in a dispute since 2019 over Walgreens' pharmacy savings club, which charged the underinsured lower drug prices but allegedly billed Humana the standard rates.
Cancer patients received letters from the prestigious Manhattan hospital in December claiming the insurer would soon drop their coverage, but there is now a tentative agreement in place to provide coverage through April 14.
A group of 19 senators sent a letter to the U.S. Department of Health and Human Services to rethink its appeal of a recent court decision permitting the use of copay accumulator programs that help patients pay for their drugs.
The pharmaceutical giant has launched a telehealth-connected website to allow patients to directly order the weight loss drug, as well as insulin products and a migraine drug, direct from the company.
Sens. Tim Kaine and Mark R. Warner, who both have championed to lower the cost of prescription drugs, applauded Sanofi, Novo Nordisk and Eli Lilly – the three major insulin manufacturers – for slashing prices, effective Jan. 1, 2024.
The Food and Drug Administration approved 55 new treatments in 2023, representing a nearly 50% increase from the year before, with Pfizer gaining the highest number of high-profile approvals covering a wide range of illnesses.